{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T12:24:31Z","timestamp":1790771071853,"version":"4.1.0"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,12]],"date-time":"2022-01-12T00:00:00Z","timestamp":1641945600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.biopha.2022.112641","type":"journal-article","created":{"date-parts":[[2022,1,17]],"date-time":"2022-01-17T05:51:34Z","timestamp":1642398694000},"page":"112641","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Protective role of activating PPAR\u03b3 in advanced glycation end products-induced impairment of coronary artery vasodilation via inhibiting p38 phosphorylation and reactive oxygen species production"],"prefix":"10.1016","volume":"147","author":[{"given":"Bing","family":"Hua","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingbo","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Side","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiping","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongwei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2022.112641_bib1","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1161\/ATVBAHA.119.310961","article-title":"Diabetes mellitus and cardiovascular disease","volume":"39","author":"Schmidt","year":"2019","journal-title":"Arterioscler.\u00a0Thromb.\u00a0Vasc. Biol."},{"key":"10.1016\/j.biopha.2022.112641_bib2","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s001250051591","article-title":"Advanced glycation end-products: a review","volume":"44","author":"Singh","year":"2001","journal-title":"Diabetologia"},{"key":"10.1016\/j.biopha.2022.112641_bib3","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1161\/01.RES.84.5.489","article-title":"Activation of receptor for advanced glycation end products: a mechanism for chronic vascular dysfunction in diabetic vasculopathy and atherosclerosis","volume":"84","author":"Schmidt","year":"1999","journal-title":"Circ. Res"},{"key":"10.1016\/j.biopha.2022.112641_bib4","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1471-2261-13-13","article-title":"Advanced glycation end products accelerate rat vascular calcification through RAGE\/oxidative stress","volume":"13","author":"Wei","year":"2013","journal-title":"BMC Cardiovasc. Disord."},{"key":"10.1016\/j.biopha.2022.112641_bib5","doi-asserted-by":"crossref","first-page":"H491","DOI":"10.1152\/ajpheart.00464.2008","article-title":"AGE\/RAGE produces endothelial dysfunction in coronary arterioles in Type 2 diabetic mice","volume":"295","author":"Gao","year":"2008","journal-title":"Am. J. Physiol.-Heart Circ. Physiol."},{"key":"10.1016\/j.biopha.2022.112641_bib6","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0142865","article-title":"Advanced glycation end products impair voltage-gated K+ channels-mediated coronary vasodilation in diabetic rats","volume":"10","author":"Su","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2022.112641_bib7","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1161\/01.ATV.0000158497.09626.3b","article-title":"Redox modulation of vascular tone","volume":"25","author":"Gutterman","year":"2005","journal-title":"Arterioscler.\u00a0Thromb.\u00a0Vasc. Biol."},{"key":"10.1016\/j.biopha.2022.112641_bib8","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1080\/mic.9.4.243.257","article-title":"New expression profiles of voltage-gated ion channels in arteries exposed to high blood pressure","volume":"9","author":"Cox","year":"2002","journal-title":"Microcirculation"},{"key":"10.1016\/j.biopha.2022.112641_bib9","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s00210-003-0834-0","article-title":"Hydrogen peroxide modulates the Kv1.5 channel expressed in a mammalian cell line","volume":"368","author":"Caouette","year":"2003","journal-title":"Naunyn-Schmiede.\u00a0Arch. Pharmacol."},{"key":"10.1016\/j.biopha.2022.112641_bib10","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.2337\/diabetes.53.9.2436","article-title":"Nitration and functional loss of voltage-gated K+ channels in rat coronary microvessels exposed to high glucose","volume":"53","author":"Li","year":"2004","journal-title":"Diabetes"},{"key":"10.1016\/j.biopha.2022.112641_bib11","doi-asserted-by":"crossref","first-page":"H1213","DOI":"10.1152\/ajpheart.00226.2003","article-title":"Elevated glucose impairs cAMP-mediated dilation by reducing Kv channel activity in rat small coronary smooth muscle cells","volume":"285","author":"Li","year":"2003","journal-title":"Am. J. Physiol.-Heart Circ. Physiol."},{"key":"10.1016\/j.biopha.2022.112641_bib12","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1172\/JCI28003","article-title":"PPAR gamma and human metabolic disease","volume":"116","author":"Semple","year":"2006","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.biopha.2022.112641_bib13","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/cr.2007.48","article-title":"Fat poetry: a kingdom for PPAR gamma","volume":"17","author":"Anghel","year":"2007","journal-title":"Cell Res."},{"key":"10.1016\/j.biopha.2022.112641_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S1462399405008793","article-title":"PPAR\u03b3 as a metabolic regulator: insights from genomics and pharmacology","volume":"7","author":"Savage","year":"2005","journal-title":"Expert Rev. Mol. Med."},{"key":"10.1016\/j.biopha.2022.112641_bib15","doi-asserted-by":"crossref","first-page":"3094","DOI":"10.1007\/s00125-006-0437-7","article-title":"Telmisartan inhibits AGE-induced C-reactive protein production through downregulation of the receptor for AGE via peroxisome proliferator-activated receptor-gamma activation","volume":"49","author":"Yoshida","year":"2006","journal-title":"Diabetologia"},{"key":"10.1016\/j.biopha.2022.112641_bib16","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.bbrc.2009.05.061","article-title":"Nifedipine, a calcium channel blocker, inhibits advanced glycation end product (AGE)-elicited mesangial cell damage by suppressing AGE receptor (RAGE) expression via peroxisome proliferator-activated receptor-gamma activation","volume":"385","author":"Matsui","year":"2009","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.biopha.2022.112641_bib17","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.3892\/mmr.2014.3113","article-title":"Pioglitazone inhibits high glucose-induced expression of receptor for advanced glycation end products in coronary artery smooth muscle cells","volume":"11","author":"Di","year":"2015","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.biopha.2022.112641_bib18","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.mce.2012.07.005","article-title":"Pioglitazone prevents hyperglycemia induced decrease of AdipoR1 and AdipoR2 in coronary arteries and coronary VSMCs","volume":"363","author":"Shen","year":"2012","journal-title":"Mol. Cell Endocrinol."},{"key":"10.1016\/j.biopha.2022.112641_bib19","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.2337\/diabetes.51.6.1938","article-title":"Hyperglycemia-induced apoptosis in mouse myocardium: mitochondrial cytochrome C-mediated caspase-3 activation pathway","volume":"51","author":"Cai","year":"2002","journal-title":"Diabetes"},{"key":"10.1016\/j.biopha.2022.112641_bib20","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.lfs.2006.08.030","article-title":"20 The ascochlorin derivative, AS-6, inhibits TNF-\u03b1-induced adhesion molecule and chemokine expression in rat vascular smooth muscle cells","volume":"80","author":"Park","year":"2006","journal-title":"Life Sci."},{"key":"10.1016\/j.biopha.2022.112641_bib21","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1161\/CIRCRESAHA.116.309491","article-title":"Contribution of KV 1.5 channel to hydrogen peroxide\u2013induced human arteriolar dilation and its modulation by coronary artery disease","volume":"120","author":"Nishijima","year":"2017","journal-title":"Circ. Res."},{"key":"10.1016\/j.biopha.2022.112641_bib22","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.cell.2016.12.028","article-title":"Structure of a pancreatic ATP-sensitive potassium channel","volume":"168","author":"Li","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.biopha.2022.112641_bib23","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.2337\/db11-0750","article-title":"The AGE-breaker ALT-711 restores high blood flow-dependent remodeling in mesenteric resistance arteries in a rat model of type 2 diabetes","volume":"61","author":"Freidja","year":"2012","journal-title":"Diabetes"},{"key":"10.1016\/j.biopha.2022.112641_bib24","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.lfs.2018.11.036","article-title":"Genistein inhibits Ang II-induced CRP and MMP-9 generations via the ER-p38\/ERK1\/2-PPAR\u03b3-NF-\u03baB signaling pathway in rat vascular smooth muscle cells","volume":"216","author":"Xu","year":"2019","journal-title":"Life Sci."},{"key":"10.1016\/j.biopha.2022.112641_bib25","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/ni.2258","article-title":"Bidirectional regulation of neutrophil migration by mitogen-activated protein kinases","volume":"13","author":"Liu","year":"2012","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.biopha.2022.112641_bib26","doi-asserted-by":"crossref","DOI":"10.1111\/micc.12380","article-title":"Roles of NADPH oxidase and mitochondria in flow-induced vasodilation of human adipose arterioles: ROS-induced ROS release in coronary artery disease","volume":"24","author":"Zinkevich","year":"2017","journal-title":"Microcirculation"},{"key":"10.1016\/j.biopha.2022.112641_bib27","doi-asserted-by":"crossref","first-page":"2661","DOI":"10.1161\/STROKEAHA.110.589895","article-title":"Leonurine protects middle cerebral artery occluded rats through antioxidant effect and regulation of mitochondrial function","volume":"41","author":"Loh","year":"2010","journal-title":"Stroke"},{"key":"10.1016\/j.biopha.2022.112641_bib28","doi-asserted-by":"crossref","first-page":"442","DOI":"10.2337\/dc10-1087","article-title":"Higher plasma levels of advanced glycation end products are associated with incident cardiovascular disease and all-cause mortality in type 1 diabetes: a 12-year follow-up study","volume":"34","author":"Nin","year":"2011","journal-title":"Diabetes Care"},{"key":"10.1016\/j.biopha.2022.112641_bib29","doi-asserted-by":"crossref","first-page":"119","DOI":"10.2337\/dc14-1435","article-title":"Ratio of serum levels of AGEs to soluble form of RAGE is a predictor of endothelial function","volume":"38","author":"Kajikawa","year":"2015","journal-title":"Diabetes Care"},{"key":"10.1016\/j.biopha.2022.112641_bib30","doi-asserted-by":"crossref","first-page":"90","DOI":"10.4330\/wjc.v4.i4.90","article-title":"Role of advanced glycation end products in cardiovascular disease","volume":"4","author":"Hegab","year":"2012","journal-title":"World J. Cardiol."},{"key":"10.1016\/j.biopha.2022.112641_bib31","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1253\/circj.CJ-13-1587","article-title":"Cardiomyocyte-derived mitochondrial superoxide causes myocardial electrical remodeling by downregulating potassium channels and related molecules","volume":"78","author":"Kurokawa","year":"2014","journal-title":"Circ. J."},{"key":"10.1016\/j.biopha.2022.112641_bib32","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1097\/HJH.0b013e328335043e","article-title":"Advanced glycation end-products induce vascular dysfunction via resistance to nitric oxide and suppression of endothelial nitric oxide synthase","volume":"28","author":"Soro-Paavonen","year":"2010","journal-title":"J. Hypertens."},{"key":"10.1016\/j.biopha.2022.112641_bib33","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1161\/ATVBAHA.108.167205","article-title":"Role of advanced glycation end products with oxidative stress in resistance artery dysfunction in type 2 diabetic mice","volume":"28","author":"Su","year":"2008","journal-title":"Arterioscler.\u00a0Thromb.\u00a0Vasc. Biol."},{"key":"10.1016\/j.biopha.2022.112641_bib34","doi-asserted-by":"crossref","DOI":"10.1111\/micc.12421","article-title":"KV channels and the regulation of vascular smooth muscle tone","volume":"25","author":"Jackson","year":"2018","journal-title":"Microcirculation"},{"key":"10.1016\/j.biopha.2022.112641_bib35","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1002\/j.2040-4603.2017.tb00747.x","article-title":"Smooth muscle ion channels and regulation of vascular tone in resistance arteries and arterioles","volume":"7","author":"Tykocki","year":"2017","journal-title":"Compr. Physiol."},{"key":"10.1016\/j.biopha.2022.112641_bib36","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1080\/10739680490425985","article-title":"K+ -induced dilation of hamster cremasteric arterioles involves both the Na+\/K+-ATPase and inward-rectifier K+ channels","volume":"11","author":"Burns","year":"2004","journal-title":"Microcirculation"},{"key":"10.1016\/j.biopha.2022.112641_bib37","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1093\/cvr\/cvy137","article-title":"Downregulation of BK channel function and protein expression in coronary arteriolar smooth muscle cells of type 2 diabetic patients","volume":"115","author":"Lu","year":"2019","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.biopha.2022.112641_bib38","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1038\/aps.2018.10","article-title":"The role of KATP channels in cerebral ischemic stroke and diabetes","volume":"39","author":"Szeto","year":"2018","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.biopha.2022.112641_bib39","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1007\/s12013-016-0763-4","article-title":"Comparison of voltage gated K+ currents in arterial myocytes with heterologously expressed Kv subunits","volume":"74","author":"Cox","year":"2016","journal-title":"Cell Biochem. Biophys."},{"key":"10.1016\/j.biopha.2022.112641_bib40","doi-asserted-by":"crossref","first-page":"279","DOI":"10.2217\/fca-2017-0019","article-title":"PPARs: regulators of metabolism and as therapeutic targets in cardiovascular disease. Part II: PPAR-\u03b2\/\u03b4 and PPAR-\u03b3","volume":"13","author":"Han","year":"2017","journal-title":"Future Cardiol."},{"key":"10.1016\/j.biopha.2022.112641_bib41","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1124\/pr.58.4.5","article-title":"International Union of pharmacology. LXI. Peroxisome proliferator-activated receptors","volume":"58","author":"Michalik","year":"2006","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.biopha.2022.112641_bib42","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1161\/CIRCRESAHA.107.164384","article-title":"Peroxisome proliferator-activated receptor-\u03b3\u2013mediated effects in the vasculature","volume":"102","author":"Duan","year":"2008","journal-title":"Circ. Res."},{"key":"10.1016\/j.biopha.2022.112641_bib43","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1253\/circj.CJ-08-1071","article-title":"Peroxisome proliferator-activated receptor gamma and cardiovascular diseases","volume":"73","author":"Takano","year":"2009","journal-title":"Circ. J."},{"key":"10.1016\/j.biopha.2022.112641_bib44","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1161\/01.RES.0000031271.20771.4F","article-title":"Vascular inflammation is negatively autoregulated by interaction between CCAAT\/enhancer-binding protein-\u03b4 and peroxisome proliferator-activated receptor-\u03b3","volume":"91","author":"Takata","year":"2002","journal-title":"Circ. Res."},{"key":"10.1016\/j.biopha.2022.112641_bib45","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1253\/circj.70.605","article-title":"Tumor necrosis factor-alpha downregulates the voltage gated outward K+ current in cultured neonatal rat cardiomyocytes: a possible cause of electrical remodeling in diseased hearts","volume":"70","author":"Kawada","year":"2006","journal-title":"Circ. J."},{"key":"10.1016\/j.biopha.2022.112641_bib46","doi-asserted-by":"crossref","first-page":"e31","DOI":"10.1161\/01.RES.0000054200.44505.AB","article-title":"Role for hydrogen peroxide in flow-induced dilation of human coronary arterioles","volume":"92","author":"Miura","year":"2003","journal-title":"Circ. Res."},{"key":"10.1016\/j.biopha.2022.112641_bib47","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/nri2035","article-title":"MAPK phosphatases \u2014 regulating the immune response","volume":"7","author":"Liu","year":"2007","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.biopha.2022.112641_bib48","doi-asserted-by":"crossref","first-page":"7412","DOI":"10.3390\/ijms21197412","article-title":"p38 MAPK pathway in the heart: new insights in health and disease","volume":"21","author":"Romero-Becerra","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2022.112641_bib49","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.coph.2008.01.002","article-title":"Targeting p38-MAPK in the ischaemic heart: kill or cure?","volume":"8","author":"Bassi","year":"2008","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.biopha.2022.112641_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2019.117108","article-title":"Telmisartan inhibits oxalate and calcium oxalate crystal-induced epithelial-mesenchymal transformation via PPAR-\u03b3-AKT\/STAT3\/p38 MAPK-Snail pathway","volume":"241","author":"Liu","year":"2020","journal-title":"Life Sci."},{"key":"10.1016\/j.biopha.2022.112641_bib51","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1096\/fj.06-6822com","article-title":"Nitric oxide activation of peroxisome proliferator-activated receptor gamma through a p38 MAPK signaling pathway","volume":"21","author":"Ptasinska","year":"2007","journal-title":"FASEB J."}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332222000294?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332222000294?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T12:42:08Z","timestamp":1760100128000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332222000294"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":51,"alternative-id":["S0753332222000294"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2022.112641","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Protective role of activating PPAR\u03b3 in advanced glycation end products-induced impairment of coronary artery vasodilation via inhibiting p38 phosphorylation and reactive oxygen species production","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2022.112641","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"112641"}}